UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005228 |
|---|---|
| Receipt number | R000006187 |
| Scientific Title | Phase II study of bevacizumab and irinotecan as second-line therapy in patients with metastatic colorectal cancer previously treated with fluoropyrimidine, oxaliplatin, and bevacizumab |
| Date of disclosure of the study information | 2011/03/09 |
| Last modified on | 2016/03/09 11:19:56 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/03/09 23:04:39 | ||
| 2 | Update | 2011/03/14 12:12:52 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
| 3 | Update | 2013/03/09 10:55:59 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2014/09/19 06:21:43 | TEL Address Address TEL |
|
| 5 | Update | 2014/09/19 06:22:54 | Recruitment status |
|
| 6 | Update | 2016/03/09 11:19:56 | Recruitment status Date trial data considered complete Date analysis concluded |
